Evaluating a New Echocardiography Imaging Procedure for Evaluating Heart Function

Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT00661323
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
1
1
35
0

Study Details

Study Description

Brief Summary

Magnetic resonance imaging (MRI) and echocardiography are two imaging methods that are used to obtain pictures of the heart and assess heart function. This study will evaluate a new, four-dimensional echocardiography approach of obtaining heart images to determine if it is as effective at evaluating heart function as MRI.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    MRI is a non-invasive method of obtaining images of the body. An MRI is conducted by having a person lie down on a narrow table, which then slides into a large tunnel-like tube. Powerful magnets and radio waves scan the body and a computer records the resulting signals. An echocardiography is a non-invasive ultrasound test that uses sound waves to create images of the heart. It is performed by having a doctor move a wand-like device over a patient's chest. The device then converts sound waves into pictures of the heart. Currently, a special MRI technique is used to evaluate heart function; however, MRI is expensive and cannot be used on critically ill patients. Echocardiography can be performed at a patient's bedside and it may be a more effective way of assessing heart function. The purpose of this study is to determine the effectiveness of a new four-dimensional echocardiography approach at evaluating heart function. Results from this study may be used to diagnose and treat patients more effectively in the future.

    This study will enroll healthy people who do not have heart disease and people who are receiving chemotherapy who do not have heart disease. Participants will have a physical examination and a medical records review. MRI scans and a four-dimensional echocardiography of the heart will be performed. There will be no additional study visits.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Left Ventricular Strain Quantification From 4D Echocardiography
    Study Start Date :
    Jul 1, 2010
    Actual Primary Completion Date :
    Jun 1, 2013
    Actual Study Completion Date :
    Jun 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Healthy volunteers will be recruited through the use of an approved study recruitment flyer.

    2

    Chemotherapy patients will be approached at the time of their nuclear scan to rule out cardiac disease prior to chemotherapy. These patients will be referred to the study by their doctor for the assessment of heart function.

    Outcome Measures

    Primary Outcome Measures

    1. Establish baseline strain patterns for future studies evaluating alterations in left ventricular strain/strain rates associated with regional myocardial ischemia and injury [Measured at participants' study visit]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • No evidence of underlying cardiac disease based on history or electrocardiogram (ECG)

    • Adequate intravenous access in one arm

    Exclusion Criteria:
    • Pregnant or breastfeeding; if pre-menopausal, not practicing acceptable method of birth control

    • History of any other medical condition that is likely to hinder study conduct or pose a safety concern, in the opinion of the investigator

    • History of cardiac disease, including heart attack or heart valve disease

    • Uncontrolled high blood pressure, defined as systolic blood pressure higher than 160 mm Hg and/or diastolic pressure higher than 100 mm Hg

    • Abnormal ECG or chest pain syndrome

    • Claustrophobia

    • Resting heart rate greater than 110 bpm

    • Unable to undergo MRI procedure (e.g., pacemaker, metallic implants)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Yale University/Magnetic Resonance Research Center (MR-TAC)/Yale New Haven Hospital New Haven Connecticut United States 06520

    Sponsors and Collaborators

    • Yale University
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Albert J. Sinusas, MD, Yale University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Yale University
    ClinicalTrials.gov Identifier:
    NCT00661323
    Other Study ID Numbers:
    • 0608001734_B
    • R01HL082640
    First Posted:
    Apr 18, 2008
    Last Update Posted:
    Mar 30, 2020
    Last Verified:
    Jun 1, 2016

    Study Results

    No Results Posted as of Mar 30, 2020